The Effect of Training Frequency on Improvements in VO2max With REHIT

May 7, 2024 updated by: Niels Vollaard, University of Stirling

The Effect of Training Frequency on Improvements in Maximal Aerobic Capacity With Reduced-exertion High-intensity Interval Training (REHIT)

Many people do not manage to do the recommended amount of physical activity for improving general health and wellbeing, and a common reason for this is lack of time. Sprint interval training (SIT) has been suggested to be a time-efficient alternative to current exercise recommendations, but most SIT protocols are not actually as time-efficient as claimed. However, it has previously been shown that the training time commitment of common SIT protocols can be substantially reduced while remaining effective at improving key health markers such as aerobic fitness, insulin function and blood pressure. For example, the reduced-exertion high-intensity interval training (REHIT) protocol consists of two 20-second 'all-out' cycle sprints within a 10-minute low-intensity exercise session. There is some evidence that REHIT is just as effective at improving aerobic fitness with 2 exercise sessions per week compared to 3 or 4 sessions. However, it remains unknown if improvements in aerobic fitness are reduced if just a single REHIT session is performed each week. Therefore, the aim of the present study is to compare improvements in aerobic fitness levels between a control group (no training intervention), a group performing a single REHIT session per week, and a group performing 2 REHIT sessions per week.

Study Overview

Status

Suspended

Conditions

Detailed Description

Up to 45 apparently healthy participants will be recruited at multiple sites. Eligible participants will complete a fitness test to measure pre-training maximal aerobic capacity (V̇O2max). Participants will start cycling on a stationary bike at a low intensity (30 W). The intensity will increase by 1 W every 3 seconds until volitional exhaustion or an inability to maintain a pedalling frequency of >60 rpm. Expired O2 and CO2 will be continuously measured breath-by-breath using an online gas analyser. V̇O2max will be determined as the highest value for a 15-breath rolling average of V̇O2. V̇O2max will be accepted if at least 2 of the following criteria are met: volitional exhaustion / inability to maintain a pedal frequency of 60 rpm, RER>1.10, a plateau in V̇O2, and/or heart rate within 10 bpm of the age predicted maximum (220-age).

Participants will then be randomised into one of 3 groups, performing either 1 or 2 REHIT training sessions per week, or no training intervention (control group). Randomisation will be performed using the sealed envelope method. Participants in the control group will be asked to maintain their regular lifestyle for 6 weeks. Participants in the training groups will perform 6 weeks of REHIT. Each REHIT session involves 10 min of unloaded pedalling interspersed with 2 all-out cycle sprints against a resistance equivalent to 7.5% of the participant's body weight. Sprint duration will be 10 s in week 1, 15 s in week 2, and 20 s in the remaining 4 weeks. The first sprint will finish at 2 min and the second sprint will finish at 6 min. Participants will be instructed to start pedalling as fast as they can ~2-3 s before applying the sprint resistance, and to keep pedalling as fast as they can during the sprint. Verbal encouragement will be provided. Heart rate and power output will be measured throughout each 10-minute exercise session. The post-training V̇O2max test will be scheduled 3 days following the last training session.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Swansea, United Kingdom, SA1 8EN
        • Swansea University
    • Stirlingshire
      • Stirling, Stirlingshire, United Kingdom, FK9 4LA
        • University of Stirling
    • Worcestershire
      • Worcester, Worcestershire, United Kingdom
        • University of Worcester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Apparently healthy
  • Sedentary or recreationally active

Exclusion Criteria:

  • Classified as highly physically active on the International Physical Activity Questionnaire (IPAQ)
  • Answering 'Yes' to any of the questions of a standard Physical Activity Readiness Questionnaire (PAR-Q)
  • Resting heart rate >100 bpm
  • Resting blood pressure > 140/90 mm Hg
  • BMI > 35 kg/m2
  • Testing positive for Covid-19
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants in the control group will be asked to maintain their regular lifestyle for the duration of the study. They will not receive an intervention.
Experimental: REHIT1
Participants in the REHIT1 group will perform a single REHIT session per week for 6 weeks.
This intervention involves a single REHIT exercise session per week. REHIT involves 10 minutes of unloaded cycling on a stationary bike interspersed with two 20-second 'all-out' cycle sprints against a resistance equivalent to 7.5% of body mass.
Other Names:
  • Reduced-exertion high-intensity interval training / single session per week
Experimental: REHIT2
Participants in the REHIT2 group will perform 2 REHIT sessions per week for 6 weeks.
This intervention is the same as that for the REHIT1 intervention, but with 2 sessions per week instead of 1.
Other Names:
  • Reduced-exertion high-intensity interval training / 2 sessions per week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in maximal aerobic capacity (VO2max)
Time Frame: Pre-intervention and 3 days following completion of the intervention.
VO2max is the greatest volume of oxygen an individual can consume per minute. It is a key health marker.
Pre-intervention and 3 days following completion of the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2022

Primary Completion (Estimated)

August 1, 2025

Study Completion (Estimated)

August 1, 2025

Study Registration Dates

First Submitted

February 8, 2022

First Submitted That Met QC Criteria

February 18, 2022

First Posted (Actual)

February 21, 2022

Study Record Updates

Last Update Posted (Actual)

May 9, 2024

Last Update Submitted That Met QC Criteria

May 7, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised IPD can be provided to other researchers on request, if the data are of use to answer a valid research question.

IPD Sharing Time Frame

After completion of data collection.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Health

3
Subscribe